SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senomys(SNMX)- A Taste for Success!!!
SNMX 1.4900.0%Nov 5 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (61)4/15/2005 11:46:45 AM
From: gfp927z  Read Replies (2) of 192
 
TexasDude, Getting the GRAS designation ahead of schedule for the four savory compounds has reduced regulatory related concerns for SNMX's technology. Of course the big question now is whether Nestle will actually use the enhancers in their products. There could be several more collaborations announced this year, which could provide an additional catalyst for a higher share price. With only $3 mil in savory related royalty revenues projected for 2006 though(Smith Barney), and none from sweet/salt til 2007, the current $300+ market cap seems to represent fair value. The stock has been very resilient during the current market weakness, but I'd like to see a pullback, with perhaps $8-10 as an entry point.

Do you have a feel for how big the remaining IPO share overhang might be? Didn't the IPO lockup end several months ago? Just curious how many more shares might be out there waiting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext